Works matching DE "CYSTIC fibrosis transmembrane conductance regulator"
Results: 1401
Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis.
- Published in:
- Acta Médica Portuguesa, 2025, v. 38, n. 2, p. 117, doi. 10.20344/amp.21948
- By:
- Publication type:
- Article
Confronting the Fungus among Us in the Airways of People with Cystic Fibrosis.
- Published in:
- Annals of the American Thoracic Society, 2025, v. 22, n. 2, p. 183, doi. 10.1513/AnnalsATS.202411-1229ED
- By:
- Publication type:
- Article
Reduction in 3-Year Risk of Death or Lung Transplant for Individuals with Advanced Cystic Fibrosis Lung Disease Treated with Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- Annals of the American Thoracic Society, 2025, v. 22, n. 2, p. 302, doi. 10.1513/AnnalsATS.202405-451RL
- By:
- Publication type:
- Article
Genetic testing in the European Union: does economic evaluation matter?
- Published in:
- European Journal of Health Economics, 2012, v. 13, n. 5, p. 651, doi. 10.1007/s10198-011-0319-x
- By:
- Publication type:
- Article
Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF).
- Published in:
- Mycopathologia, 2023, v. 188, n. 5, p. 699, doi. 10.1007/s11046-023-00725-1
- By:
- Publication type:
- Article
Occurrence of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Patients with Allergic Bronchopulmonary Aspergillosis Complicating Asthma.
- Published in:
- Mycopathologia, 2022, v. 187, n. 2/3, p. 147, doi. 10.1007/s11046-022-00631-y
- By:
- Publication type:
- Article
CF Fungal Disease in the Age of CFTR Modulators.
- Published in:
- Mycopathologia, 2021, v. 186, n. 5, p. 655, doi. 10.1007/s11046-021-00541-5
- By:
- Publication type:
- Article
Generation of ΔF508-CFTR T84 cell lines by CRISPR/Cas9-mediated genome editing.
- Published in:
- Biotechnology Letters, 2016, v. 38, n. 12, p. 2023, doi. 10.1007/s10529-016-2190-4
- By:
- Publication type:
- Article
Drug-set enrichment analysis: a novel tool to investigate drug mode of action.
- Published in:
- Bioinformatics, 2016, v. 32, n. 2, p. 235, doi. 10.1093/bioinformatics/btv536
- By:
- Publication type:
- Article
The bidirectional relationship between CFTR and lipids.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. 1, doi. 10.1038/s42003-020-0909-1
- By:
- Publication type:
- Article
Molecular mechanisms of Cl<sup>−</sup> transport in fishes: New insights and their evolutionary context.
- Published in:
- Journal of Experimental Zoology: Part A Ecological & Integrative Physiology, 2021, v. 335, n. 2, p. 207, doi. 10.1002/jez.2428
- By:
- Publication type:
- Article
Additional evidence on the phenotype produced by combination of CFTR 1677delTA alleles and their relevance in causing CFTR-related disease.
- Published in:
- SAGE Open Medical Case Reports, 2023, p. 1, doi. 10.1177/2050313X231177163
- By:
- Publication type:
- Article
Successful Desensitization With ELX/TEZ/IVA.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 5, p. 539, doi. 10.5863/1551-6776-29.5.539
- By:
- Publication type:
- Article
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Pseudomonas aeruginosa Acquisition and Chronic Infection at a Single Pediatric Cystic Fibrosis Care Center.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2024, v. 29, n. 2, p. 135, doi. 10.5863/1551-6776-29.2.135
- By:
- Publication type:
- Article
Elexacaftor-Tezacaftor-Ivacaftor: The First Triple- Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapy.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 3, p. 192, doi. 10.5863/1551-6776-25.3.192
- By:
- Publication type:
- Article
Clinical and prognostic importance of chromosomal abnormalities, Y chromosome microdeletions, and CFTR gene mutations in individuals with azoospermia or severe oligospermia.
- Published in:
- Turkish Journal of Medical Sciences, 2014, v. 44, n. 2, p. 347, doi. 10.3906/sag-1301-67
- By:
- Publication type:
- Article
Chronic rhinosinusitis in patients with cystic fibrosis—Current management and new treatments.
- Published in:
- Laryngoscope Investigative Otolaryngology, 2020, v. 5, n. 3, p. 368, doi. 10.1002/lio2.401
- By:
- Publication type:
- Article
Clinical relevance of Pseudomonas aeruginosa viable but non-culturable forms in cystic fibrosis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 9, p. 1865, doi. 10.1007/s10096-024-04890-z
- By:
- Publication type:
- Article
Inflammation‐induced loss of CFTR‐expressing airway ionocytes in non‐eosinophilic asthma.
- Published in:
- Respirology, 2025, v. 30, n. 1, p. 25, doi. 10.1111/resp.14833
- By:
- Publication type:
- Article
Abstracts of the 15th Australasian Cystic Fibrosis Conference, 2‐4 August 2024.
- Published in:
- Respirology, 2024, v. 29, p. 3, doi. 10.1111/resp.14771
- Publication type:
- Article
TSANZ Abstracts.
- Published in:
- Respirology, 2024, v. 29, p. 25, doi. 10.1111/resp.14673
- Publication type:
- Article
Monoclonal antibody therapy in cystic fibrosis and asthma.
- Published in:
- Respirology, 2023, v. 28, n. 6, p. 571, doi. 10.1111/resp.14498
- By:
- Publication type:
- Article
Innovative cystic fibrosis drug development: A perspective.
- Published in:
- Respirology, 2022, v. 27, n. 12, p. 1015, doi. 10.1111/resp.14380
- By:
- Publication type:
- Article
STUB1 exacerbates calcium oxalate-induced kidney injury by modulating reactive oxygen species-mediated cellular autophagy via regulating CFTR ubiquitination.
- Published in:
- Urolithiasis, 2024, v. 52, n. 1, p. 1, doi. 10.1007/s00240-024-01547-6
- By:
- Publication type:
- Article
STUB1 exacerbates calcium oxalate-induced kidney injury by modulating reactive oxygen species-mediated cellular autophagy via regulating CFTR ubiquitination.
- Published in:
- Urolithiasis, 2024, v. 52, n. 1, p. 1, doi. 10.1007/s00240-024-01547-6
- By:
- Publication type:
- Article
Urinary stone disease prevalence and associations in cystic fibrosis.
- Published in:
- Urolithiasis, 2021, v. 49, n. 5, p. 415, doi. 10.1007/s00240-021-01244-8
- By:
- Publication type:
- Article
Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41868-x
- By:
- Publication type:
- Article
Enhancing the performance of a mutant pyrrolysyl-tRNA synthetase to create a highly versatile eukaryotic cell-free protein synthesis tool.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42198-8
- By:
- Publication type:
- Article
Enhancing the performance of a mutant pyrrolysyl-tRNA synthetase to create a highly versatile eukaryotic cell-free protein synthesis tool.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42198-8
- By:
- Publication type:
- Article
Cystic fibrosis-related mortality in the United States from 1999 to 2020: an observational analysis of time trends and disparities.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41868-x
- By:
- Publication type:
- Article
Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38300-9
- By:
- Publication type:
- Article
Editorial: Advancing therapeutic strategies: exploring ABC transporters and chemicals affecting their expression and function for disease treatment.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1423979
- By:
- Publication type:
- Article
Editorial: Advancing therapeutic strategies: exploring ABC transporters and chemicals affecting their expression and function for disease treatment.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1423979
- By:
- Publication type:
- Article
Readthrough-induced misincorporated amino acid ratios guide mutant-specific therapeutic approaches for two CFTR nonsense mutations.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1389586
- By:
- Publication type:
- Article
Ligand-based virtual-screening identified a novel CFTR ligand which improves the defective cell surface expression of misfolded ABC transporters.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1370676
- By:
- Publication type:
- Article
Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1362325
- By:
- Publication type:
- Article
Comparing ATPase activity of ATP-binding cassette subfamily C member 4, lamprey CFTR, and human CFTR using an antimony-phosphomolybdate assay.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1363456
- By:
- Publication type:
- Article
Editorial: Real-world experience with CFTR modulator therapy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1331829
- By:
- Publication type:
- Article
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/ tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1167407
- By:
- Publication type:
- Article
A review of the pathophysiology and the role of ion channels on bronchial asthma.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1236550
- By:
- Publication type:
- Article
Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1245885
- By:
- Publication type:
- Article
Ocular development after highly effective modulator treatment early in life.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1265138
- By:
- Publication type:
- Article
Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1157459
- By:
- Publication type:
- Article
Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1171544
- By:
- Publication type:
- Article
Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1180826
- By:
- Publication type:
- Article
Effects of lumacaftor--ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1188051
- By:
- Publication type:
- Article
Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1176815
- By:
- Publication type:
- Article
Individualized approach to elexacaftor/tezacaftor/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1156621
- By:
- Publication type:
- Article
Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function.
- Published in:
- Frontiers in Pharmacology, 2017, v. 8, p. 1, doi. 10.3389/fphar.2017.00195
- By:
- Publication type:
- Article
CFTR Depletion Confers Hypersusceptibility to Mycobacterium fortuitum in a Zebrafish Model.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. 1, doi. 10.3389/fcimb.2020.00357
- By:
- Publication type:
- Article